Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 1336
of 67Next
1:

Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health.

Health Qual Life Outcomes. 2006 Oct 11;4:79.

PMID: 17034633 [PubMed - indexed for MEDLINE]

2:

Patient-reported outcomes supporting anticancer product approvals.

Rock EP, Kennedy DL, Furness MH, Pierce WF, Pazdur R, Burke LB.

J Clin Oncol. 2007 Nov 10;25(32):5094-9. Review.

PMID: 17991927 [PubMed - indexed for MEDLINE]

3:

Responsiveness and minimal important differences for patient reported outcomes.

Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK.

Health Qual Life Outcomes. 2006 Sep 27;4:70.

PMID: 17005038 [PubMed - indexed for MEDLINE]

4:

Patient-reported outcomes to support medical product labeling claims: FDA perspective.

Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL.

Value Health. 2007 Nov-Dec;10 Suppl 2:S125-37. Review.

PMID: 17995471 [PubMed - indexed for MEDLINE]

5:

Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.

Willke RJ, Burke LB, Erickson P.

Control Clin Trials. 2004 Dec;25(6):535-52. Review.

PMID: 15588741 [PubMed - indexed for MEDLINE]

6:

Patient-reported outcomes: conceptual issues.

Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.

Value Health. 2007 Nov-Dec;10 Suppl 2:S66-75.

PMID: 17995476 [PubMed - indexed for MEDLINE]

7:

Patient-reported outcome instrument selection: designing a measurement strategy.

Snyder CF, Watson ME, Jackson JD, Cella D, Halyard MY; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.

Value Health. 2007 Nov-Dec;10 Suppl 2:S76-85.

PMID: 17995477 [PubMed - indexed for MEDLINE]

8:

Documenting the rationale and psychometric characteristics of patient reported outcomes for labeling and promotional claims: the PRO Evidence Dossier.

Revicki DA, Gnanasakthy A, Weinfurt K.

Qual Life Res. 2007 May;16(4):717-23. Epub 2007 Feb 1.

PMID: 17268927 [PubMed - indexed for MEDLINE]

9:

How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure.

Brozek JL, Guyatt GH, Schünemann HJ.

Health Qual Life Outcomes. 2006 Sep 27;4:69.

PMID: 17005037 [PubMed - indexed for MEDLINE]

10:

Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001.

Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M; PRO Harmonization Group.

Value Health. 2003 Sep-Oct;6(5):522-31.

PMID: 14627058 [PubMed - indexed for MEDLINE]

11:

Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.

Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T.

J Sex Marital Ther. 2005 Mar-Apr;31(2):153-66. Review.

PMID: 15859374 [PubMed - indexed for MEDLINE]

12:

The FDA guidance for industry on PROs: the point of view of a pharmaceutical company.

Arpinelli F, Bamfi F.

Health Qual Life Outcomes. 2006 Oct 31;4:85.

PMID: 17076891 [PubMed - indexed for MEDLINE]

13:

[The origin of informed consent]

Mallardi V.

Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Italian.

PMID: 16602332 [PubMed - indexed for MEDLINE]

14:

Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.

Wiklund I.

Fundam Clin Pharmacol. 2004 Jun;18(3):351-63. Review.

PMID: 15147288 [PubMed - indexed for MEDLINE]

16:

What is sufficient evidence for the reliability and validity of patient-reported outcome measures?

Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group;.

Value Health. 2007 Nov-Dec;10 Suppl 2:S94-S105.

PMID: 17995479 [PubMed - indexed for MEDLINE]

17:

Regulatory issues for health-related quality of life--PhRMA Health Outcomes Committee workshop, 1999.

Santanello NC, Baker D, Cappelleri JC, Copley-Merriman K, DeMarinis R, Gagnon JP, Hsuan A, Jackson J, Mahmoud R, Miller D, Morgan M, Osterhaus J, Tilson H, Willke R.

Value Health. 2002 Jan-Feb;5(1):14-25.

PMID: 11873379 [PubMed - indexed for MEDLINE]

18:

The regulation of patient-reported outcome claims: need for a flexible standard.

Morris LA, Miller DW.

Value Health. 2002 Jul-Aug;5(4):372-81. Review.

PMID: 12102699 [PubMed - indexed for MEDLINE]

19:

Meeting on the FDA draft guidance on patient-reported outcomes.

Dueck AC, Sloan JA.

Value Health. 2007 Nov-Dec;10 Suppl 2:S64-5. No abstract available.

PMID: 17995475 [PubMed - indexed for MEDLINE]

20:

Patient-reported outcomes: instrument development and selection issues.

Turner RR, Quittner AL, Parasuraman BM, Kallich JD, Cleeland CS; Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group.

Value Health. 2007 Nov-Dec;10 Suppl 2:S86-93.

PMID: 17995478 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 1336
of 67Next